Neurocrine Biosciences, Inc. · NASDAQ:NBIX
JPMorgan Chase & Co reported a 5.20% stake in Neurocrine Biosciences, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
JPMorgan Chase & Co reported a 5.20% stake in Neurocrine Biosciences, Inc., 5,198,084 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 5,198,084
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 5.20% | 5,198,084 |
Source
Related
- Neurocrine Biosciences, Inc.
- JPMorgan Chase & Co
- Neurocrine Biosciences, Inc. shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Jul 27, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026
- Form 4 · Lippoldt Darin · Sep 15, 2026